RESLIZUMAB

Overview

RESLIZUMAB is a Schedule H drug.
Reslizumab is a monoclonal antibody that affects the actions of the body’s immune system. Reslizumab works by reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma.Reslizumab is used together with other medicines to help control severe asthma in adults.Reslizumab is not used to treat sudden breathing problems.It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier.

Usage

RESLIZUMAB is generally used to treat: Asthma
RESLIZUMAB can address symptoms like: Wheezing, Shortness Of Breath, Cough, Difficulty Breathing, Throat Irritation, Rapid Breathing

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

  • You should not be treated with reslizumab if you are allergic to it.
  • Before you start treatment with reslizumab, your doctor may perform tests to measure your levels of a certain type of white blood cell (eosinophils).
  • Reslizumab is given once every 4 weeks and is injected into a vein through an IV.
  • Reslizumab must be given slowly. The IV infusion can take up to 50 minutes to complete.
  • You will be watched closely for a short time after receiving your injection, to make sure you do not have an allergic reaction.
  • Reslizumab is not a rescue medicine.
  • It will not work fast enough to treat an asthma attack. Use only a fast acting inhalation medicine for an asthma attack.Avoid using the drug if there is any signs of parasitic infections.
  • Do not discontinue corticosteroid drugs while initiating reslizumab therapy as it might result in withdrawal symptoms.

Common Side-Effects

RESLIZUMAB : Muscle Pain, Skin Rash, Itchy Skin, Throat Soreness, Throat Irritation, Nausea, Dizziness, Lightheadedness, Face Swelling, Swollen Lips

Rare Side-Effects

RESLIZUMAB : Cancer

Technical Classification

RESLIZUMAB is categorized as: INTERLEUKIN INHIBITORS / IMMUNOSUPPRESSIVE AGENTS / IMMUNOLOGIC AGENTS

Storage Conditions

Refrigeration (Between 2 To 8 C)

Available Alternatives

What are the other drugs with similar Ingredients?

RESLIZUMABRESLIZUMAB